118 related articles for article (PubMed ID: 28007596)
1. Soft matrices downregulate FAK activity to promote growth of tumor-repopulating cells.
Tan Y; Wood AR; Jia Q; Zhou W; Luo J; Yang F; Chen J; Chen J; Sun J; Seong J; Tajik A; Singh R; Wang N
Biochem Biophys Res Commun; 2017 Jan; 483(1):456-462. PubMed ID: 28007596
[TBL] [Abstract][Full Text] [Related]
2. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression.
Tan Y; Tajik A; Chen J; Jia Q; Chowdhury F; Wang L; Chen J; Zhang S; Hong Y; Yi H; Wu DC; Zhang Y; Wei F; Poh YC; Seong J; Singh R; Lin LJ; Doğanay S; Li Y; Jia H; Ha T; Wang Y; Huang B; Wang N
Nat Commun; 2014 Aug; 5():4619. PubMed ID: 25099074
[TBL] [Abstract][Full Text] [Related]
3. Efficient extravasation of tumor-repopulating cells depends on cell deformability.
Chen J; Zhou W; Jia Q; Chen J; Zhang S; Yao W; Wei F; Zhang Y; Yang F; Huang W; Zhang Y; Zhang H; Zhang Y; Huang B; Zhang Z; Jia H; Wang N
Sci Rep; 2016 Jan; 6():19304. PubMed ID: 26787224
[TBL] [Abstract][Full Text] [Related]
4. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of YAP-dependent Nupr1 promotes tumor-repopulating cell growth in soft matrices.
Jia Q; Zhou W; Yao W; Yang F; Zhang S; Singh R; Chen J; Chen JJ; Zhang Y; Wei F; Zhang Y; Jia H; Wang N
Oncogenesis; 2016 Apr; 5(4):e220. PubMed ID: 27089143
[TBL] [Abstract][Full Text] [Related]
6. Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program.
Liu Y; Lv J; Liang X; Yin X; Zhang L; Chen D; Jin X; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Xie J; Wang N; Huang B
Cancer Res; 2018 Jul; 78(14):3926-3937. PubMed ID: 29764867
[TBL] [Abstract][Full Text] [Related]
7. Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways.
Tan X; Xu A; Zhao T; Zhao Q; Zhang J; Fan C; Deng Y; Freywald A; Genth H; Xiang J
Sci Rep; 2018 Feb; 8(1):3769. PubMed ID: 29491429
[TBL] [Abstract][Full Text] [Related]
8. Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer.
Ni S; Hu J; Duan Y; Shi S; Li R; Wu H; Qu Y; Li Y
Cancer Sci; 2013 Jul; 104(7):817-25. PubMed ID: 23521319
[TBL] [Abstract][Full Text] [Related]
9. Simulated Microgravity Reduces Focal Adhesions and Alters Cytoskeleton and Nuclear Positioning Leading to Enhanced Apoptosis via Suppressing FAK/RhoA-Mediated mTORC1/NF-κB and ERK1/2 Pathways.
Zhao T; Li R; Tan X; Zhang J; Fan C; Zhao Q; Deng Y; Xu A; Lukong KE; Genth H; Xiang J
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986550
[TBL] [Abstract][Full Text] [Related]
10. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.
Lim Y; Lim ST; Tomar A; Gardel M; Bernard-Trifilo JA; Chen XL; Uryu SA; Canete-Soler R; Zhai J; Lin H; Schlaepfer WW; Nalbant P; Bokoch G; Ilic D; Waterman-Storer C; Schlaepfer DD
J Cell Biol; 2008 Jan; 180(1):187-203. PubMed ID: 18195107
[TBL] [Abstract][Full Text] [Related]
11. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
Oppel F; Müller N; Schackert G; Hendruschk S; Martin D; Geiger KD; Temme A
Mol Cancer; 2011 Nov; 10():137. PubMed ID: 22070920
[TBL] [Abstract][Full Text] [Related]
12. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
Park JH; Ryu JM; Han HJ
J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
14. Cdc42-dependent modulation of rigidity sensing and cell spreading in tumor repopulating cells.
Chowdhury F; Doğanay S; Leslie BJ; Singh R; Amar K; Talluri B; Park S; Wang N; Ha T
Biochem Biophys Res Commun; 2018 Jun; 500(3):557-563. PubMed ID: 29673588
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase regulates laminin-induced oligodendroglial process outgrowth.
Hoshina N; Tezuka T; Yokoyama K; Kozuka-Hata H; Oyama M; Yamamoto T
Genes Cells; 2007 Nov; 12(11):1245-54. PubMed ID: 17986008
[TBL] [Abstract][Full Text] [Related]
17. Promyogenic function of Integrin/FAK signaling is mediated by Cdo, Cdc42 and MyoD.
Han JW; Lee HJ; Bae GU; Kang JS
Cell Signal; 2011 Jul; 23(7):1162-9. PubMed ID: 21397010
[TBL] [Abstract][Full Text] [Related]
18. RacGAP1-driven focal adhesion formation promotes melanoma transendothelial migration through mediating adherens junction disassembly.
Zhang P; Bai H; Fu C; Chen F; Zeng P; Wu C; Ye Q; Dong C; Song Y; Song E
Biochem Biophys Res Commun; 2015 Mar; 459(1):1-9. PubMed ID: 25475728
[TBL] [Abstract][Full Text] [Related]
19. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
20. Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis.
Kaneda T; Sonoda Y; Ando K; Suzuki T; Sasaki Y; Oshio T; Tago M; Kasahara T
Cancer Lett; 2008 Nov; 270(2):354-61. PubMed ID: 18606490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
